Med-Tech Innovation January 25, 2022
RadNet, a provider of fixed-site outpatient diagnostic imaging services has acquired Aidence, a radiology AI company focussing on AI-enabled clinical solutions for pulmonary nodule management in routine practice and lung cancer screening.
Founded in 2015 and based in Amsterdam, the Netherlands, Aidence is developing and deploying AI clinical applications to empower radiologists and other physicians in interpreting medical images and improving patient outcomes. Aidence’s first commercialised product, Veye Lung Nodules, is an AI-based solution for lung nodule detection classification, quantification, and growth assessment. This product is CE marked.
Aidence’s solution analyses thousands of CT scans each week, with customers in seven European countries including France, the Netherlands, and the UK. In 2020, Aidence received an AI...
Today's Sponsors
Today's Sponsor